Back to BlackRock, Inc. BlackRock, Inc.

DYNDYN
7 quarters

Position history for BlackRock, Inc.BlackRock, Inc.'s holdings in DYNE THERAPEUTICS INC

BlackRock, Inc. holds 12.4M shares of DYN (DYNE THERAPEUTICS INC), worth $275.5M as of 2026-Q2. The position was increased (+6.0% shares). DYN represents 0.0% of BlackRock, Inc.'s portfolio.

Current Value

$275.5M

Current Shares

12.4M

Total Value Change

+$88.2M

Total Shares Change

+4.5M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
12.4M
+6.0%
$275.5M0.0%$22.21
33
2026-Q1
Increased
11.7M
+4.5%
$212.1M0.0%$14.60
32
2025-Q4
Increased
11.2M
+16.1%
$218.9M0.0%$19.20
35
2025-Q3
Increased
9.6M
+19.3%
$121.9M0.0%$12.37
36
2025-Q2
Increased
8.1M
+0.4%
$76.9M0.0%$9.57
30
2025-Q1
Increased
8M
+1.2%
$84.2M0.0%$11.45
30
2024-Q4
New
7.9M
-
$187.3M0.0%$23.65
42

Other major holders of DYN: Janus Henderson Group Ltd., BlackRock Finance, Inc., FMR LLC, VANGUARD GROUP INC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used